Goldenberg I, Matetzky S. Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies [J]. CMAJ,2005,172(11): 1461-1471.
[3]
Lameire N, Van Biesen W, Vanholder R. Acute renal failure[J]. Lancet, 2005，365 (9457):417-430.
Tanaka A, Suzuki Y, Suzuki N, et al. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction [J].Intern Med, 2011,50(7):673-677.
Piskinpasa S, Altun B, Akoglu H, et al.An uninvestigated risk factor for contrast-induced nephropathy in chronic kidney disease:proteinuria[J]. Ren Fail,2013,35(1):62-65.
[8]
Subedi B, Siddique MA, Zaman SM, et al. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty [J]. Mymensingh Med J,2011,20(2):270-274.
[9]
Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium- induced nephropathy[J].Kidney Int，2005，68(1):14-22.
[10]
Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: Development and initial validation[J]. J Am Coll Cardiol, 2004,44(7):1393-1399.
